Treatment patterns, persistence with therapy, and outcomes of ustekinumab in Crohn's disease: Real‐world data analysis

BACKGROUND AND AIM: In 2017, ustekinumab (UST) was included in Israel's National Basket of Health Services for treatment of biologic‐experienced Crohn's disease (CD) patients with moderately to severely active disease. This study aims to provide real‐world evidence on persistence and clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Banon, Tamar, Weil, Clara, Borsi, Andras, Chodick, Gabriel, Shakked, Zehavi, Barit Ben‐David, Nava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829097/
https://www.ncbi.nlm.nih.gov/pubmed/35155821
http://dx.doi.org/10.1002/jgh3.12670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829097/
https://www.ncbi.nlm.nih.gov/pubmed/35155821
http://dx.doi.org/10.1002/jgh3.12670

Ejemplares similares